KFG Wealth Management’s Idexx Laboratories IDXX Stock Holding History

KFG Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$490K	Buy	930 +9	+1%	+$5.05K	0.06%	141
2026 Q1	$518K	Sell	921 -7	-0.8%	-$4.49K	0.07%	129
2025 Q4	$628K	Sell	928 -94	-9%	-$64K	0.08%	107
2025 Q3	$653K	Sell	1,022 -400	-28%	-$243K	0.09%	105
2025 Q2	$763K	Buy	1,422 +31	+2%	+$14.8K	0.12%	94
2025 Q1	$584K	Buy	1,391 +299	+27%	+$130K	0.11%	109
2024 Q4	$451K	Buy	1,092 +99	+10%	+$43.4K	0.08%	117
2024 Q3	$502K	Buy	993 +49	+5%	+$23.8K	0.11%	113
2024 Q2	$460K	Buy	944 +48	+5%	+$24.1K	0.18%	100
2024 Q1	$484K	Sell	896 -73	-8%	-$39.9K	0.2%	93
2023 Q4	$538K	Buy	+969	New	+$455K	0.25%	71

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

KFG Wealth Management's IDXX Position: Q2 2026 in Review

KFG Wealth Management increased its Idexx Laboratories (IDXX) stake by 0.98% in Q2 2026, buying an estimated $5.05K and bringing the position to 930 shares worth $490K. The position accounts for 0.06% of the portfolio, ranked #141.

KFG Wealth Management first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $763K in Q2 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

KFG Wealth Management held 930 shares of Idexx Laboratories worth $490K as of Q2 2026.
KFG Wealth Management bought 9 Idexx Laboratories shares in Q2 2026, an estimated $5.05K.
Idexx Laboratories made up 0.06% of KFG Wealth Management's portfolio in Q2 2026, its #141 holding.
KFG Wealth Management first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
KFG Wealth Management's Idexx Laboratories position peaked at $763K in Q2 2025.
1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on KFG Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.